An adherence club helped almost all patients stay on their treatment.
Research predicts a substantial shortfall in HIV funding in the next five years as the country looks to put millions more people on treatment.
As the world’s biggest consumer of ARVs, South Africa spends billions of rands purchasing the drugs on the international market every year.
The nation's healthcare system reflects the actions of the ministers responsible for it over the years.
Bhekisisa director Mia Malan speaks on The Science Inside show about ARV shortages on Voice of Wits radio station.
Between 2004 and 2012, the number of new HIV infections have decreased from an estimated 540 000 to 370 000, shows a UNAids report.
A new study to be conducted in South Africa, Uganda and India has sparked a heated debate in the HIV activist and research community.
The hunt is on for a new private sector partner with the expertise to set up a drug-making plan.
Access to ARVs is improving, but poor attitudes to patients are aggravating maternal mortality rates.
As the fallout regarding misinformation about vaccines and antiretrovirals shows, words can kill.
Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.
New medicine combines ARVs into one pill, making them easier to supply.
ARVs have slowed down the rate of new HIV infections and increased the life expectancy of the general population in rural KZN
Hundreds of people with HIV took to the streets of Swaziland to protest over poor health service delivery and a reported shortage of ARV treatment.
Health economists say increasing the uptake of antiretroviral treatment to meet the state's targets will require an additional R10bn a year in funding
The Global Fund to Fight Aids, Malaria and TB, the largest funder of Aids programmes worldwide, has an estimated shortfall of $3-billion to $5-billion